Early interception of lung disease through Artificial Intelligence.
Optellum was founded so that every lung cancer patient, in every hospital, is treated at an early stage and cured. Our vision is to redefine early interception of lung disease, by enabling clinicians to manage their patients in the optimal way.
Our first product is the world's first precision medicine software for early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset.
We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. Learn more at http://www.optellum.com/.